NEW YORK, NY / ACCESSWIRE / July 7, 2022 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Axsome Therapeutics, Inc. (NASDAQ:AXSM)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/axsome-therapeutics-inc-loss-submission-form?prid=29641&wire=1
Lead Plaintiff Deadline: July 12, 2022
Class Period: December 30, 2019 – April 22, 2022
Allegations against AXSM include that: (i) Axsome’s chemistry, manufacturing, and control (“CMC”) practices were deficient with respect to AXS-07, the Company’s medicine for the acute treatment of migraine, and its manufacturing process; (ii) as a result, Axsome was unlikely to submit the AXS-07 New Drug Application (“NDA”) on its initially represented timeline; (iii) the foregoing CMC issues remained unresolved at the time that the U.S. Food and Drug Administration (“FDA”) reviewed the AXS-07 NDA; (iv) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (v) as a result of all the foregoing, Axsome had overstated AXS-07’s regulatory and commercial prospects; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.
IonQ, Inc. (NYSE:IONQ)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/ionq-inc-loss-submission-form?prid=29641&wire=1
Lead Plaintiff Deadline: August 1, 2022
Class Period: March 30, 2021 – May 2, 2022
Allegations against IONQ include that: (1) IonQ had not yet developed a 32-qubit quantum computer; (2) the Company’s 11-qubit quantum computer suffered from significant error rates, rendering it useless; (3) IonQ’s quantum the computer is not sufficiently reliable, so it is not accessible despite being available through major cloud providers; (4) a significant portion of IonQ’s revenue was derived from improper roundtripping transactions with related parties; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were the materially misleading and/or lacked a reasonable basis.
Inotiv, Inc. (NASDAQ:NOTV)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/inotiv-shareholder-loss-submission-form?prid=29641&wire=1
Lead Plaintiff Deadline: August 22, 2022
Class Period: September 21, 2021 – June 13, 2022
Allegations against NOTV include that: (1) Inotiv’s acquisition, Envigo RMS, LL (“Envigo”), and Inotiv’s Cumberland, Virginia facility (the “Cumberland Facility”) engaged in widespread and flagrant violations of the Animal Welfare Act (“AWA”); (2) Envigo and Inotiv’s Cumberland Facility continuously violated the AWA; (3) Envigo and Inotiv did not properly remedy issues with regards to animal welfare at the Cumberland Facility; (4) as a result, Inotiv was likely to face increased scrutiny and governmental action; (5) Inotiv would imminently shut down two facilities, including the Cumberland Facility; (6) Inotiv did not engage in proper due diligence; and (7) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com:
https://www.accesswire.com/707956/SHAREHOLDER-ALERT-AXSM-IONQ-NOTV-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines
